The Patent Finder

A Method of Increasing Red Blood Cell Levels or Treating Anemia in a Patient

Acceleron Pharma Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 15 of these applications claim priority to application 61/189,094, filed Aug 14, 2008. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 8,216,997Methods for Increasing Red Blood Cell Levels and Treating Anemia Using a Combination of GDF Traps and Erythropoietin Receptor Activators
In force
 · High confidence
UsedRemaining
Acceleron Pharma Inc.In forceHigh confidence
US 8,361,957An Isolated GDF Trap Polypeptide
In force
 · High confidence
Acceleron Pharma, Inc.In forceHigh confidence
US 8,703,927Isolated Nucleotide Sequences Encoding GDF Traps
In force
 · High confidence
Acceleron Pharma Inc.In forceHigh confidence
US 9,439,945Isolated Nucleotide Sequences Encoding GDF Traps
In force
 · High confidence
Acceleron Pharma Inc.In forceHigh confidence
US 9,505,813Use of GDF Traps to Treat Anemia
In force
 · High confidence
Acceleron Pharma Inc.In forceHigh confidence
US 9,932,379Isolated Nucleotide Sequences Encoding GDF Traps
In force
 · Medium confidence
Acceleron Pharma Inc.In forceMedium confidence
US 10,131,700Methods for Treating Refractory Anemia with Ringed Sideroblasts
In force
 · Medium confidence
Acceleron Pharma Inc.In forceMedium confidence
US 10,377,996Isolated GDF Trap Polypeptide
In force
 · High confidence
Acceleron Pharma Inc.In forceHigh confidence
US 10,689,427Combined Use of GDF Traps and Erythropoietin Receptor Activators to Increase Red Blood Cell Levels
In force
 · Medium confidence
Acceleron Pharma Inc.In forceMedium confidence
US 10,829,532Combined Use of GDF Traps and Erythropoietin Receptor Activators to Increase Red Blood Cell Levels
In force
 · Medium confidence
Acceleron Pharma Inc.In forceMedium confidence
10 more records in this group · Pro
10 of 20 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 20.
Upgrade to Pro
16 of these are in force and held by Acceleron Pharma Inc..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited